(Q35587607)

9 August 2017

1 reference

title

Minimizing prostate brachytherapy-related morbidity (English)

1 reference

9 August 2017

1 reference

Gregory S Merrick

1

1 reference

9 August 2017

Kent E Wallner

series ordinal

2

1 reference

9 August 2017

Wayne M Butler

series ordinal

3

1 reference

9 August 2017

language of work or name

English

0 references

publication date

1 November 2003

1 reference

9 August 2017

1 reference

9 August 2017

volume

62

1 reference

9 August 2017

issue

5

1 reference

9 August 2017

page(s)

786-792

1 reference

Permanent interstitial brachytherapy for the management of carcinoma of the prostate gland

9 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2803%2900558-2

7 January 2021

Relationship between percent positive biopsies and biochemical outcome after permanent interstitial brachytherapy for clinically organ-confined carcinoma of the prostate gland.

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2803%2900558-2

7 January 2021

A prospective quality-of-life study in men with clinically localized prostate carcinoma treated with radical prostatectomy, external beam radiotherapy, or interstitial brachytherapy.

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2803%2900558-2

7 January 2021

Comprehensive comparison of health-related quality of life after contemporary therapies for localized prostate cancer.

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2803%2900558-2

7 January 2021

LONG-TERM TREATMENT RELATED COMPLICATIONS OF BRACHYTHERAPY FOR EARLY PROSTATE CANCER: A SURVEY OF PATIENTS PREVIOUSLY TREATED

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2803%2900558-2

7 January 2021

Long-term urinary quality of life after permanent prostate brachytherapy

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2803%2900558-2

7 January 2021

A dose-response study for I-125 prostate implants

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2803%2900558-2

7 January 2021

The dosimetry of prostate brachytherapy-induced urethral strictures

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2803%2900558-2

7 January 2021

Defining the risk of developing grade 2 proctitis following 125I prostate brachytherapy using a rectal dose-volume histogram analysis

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2803%2900558-2

7 January 2021

The importance of radiation doses to the penile bulb vs. crura in the development of postbrachytherapy erectile dysfunction.

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2803%2900558-2

7 January 2021

Factors influencing risk of acute urinary retention after TRUS-guided permanent prostate seed implantation

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2803%2900558-2

7 January 2021

Temporal resolution of urinary morbidity following prostate brachytherapy

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2803%2900558-2

7 January 2021

Identification of patients at increased risk for prolonged urinary retention following radioactive seed implantation of the prostate.

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2803%2900558-2

7 January 2021

Late urinary function after prostate brachytherapy

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2803%2900558-2

7 January 2021

Identifying the predictors of acute urinary retention following magnetic-resonance-guided prostate brachytherapy

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2803%2900558-2

7 January 2021

Prophylactic versus therapeutic alpha-blockers after permanent prostate brachytherapy

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2803%2900558-2

7 January 2021

Acute urinary morbidity following I-125 interstitial implantation of the prostate gland

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2803%2900558-2

7 January 2021

Dysuria after permanent prostate brachytherapy.

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2803%2900558-2

7 January 2021

Relationship between the transition zone index of the prostate gland and urinary morbidity after brachytherapy

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2803%2900558-2

7 January 2021

Complications following permanent prostate brachytherapy

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2803%2900558-2

7 January 2021

Dosimetry guidelines to minimize urethral and rectal morbidity following transperineal I-125 prostate brachytherapy

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2803%2900558-2

7 January 2021

Proximity of prostate cancer to the urethra: implications for minimally invasive ablative therapies

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2803%2900558-2

7 January 2021

Clinical correlates of high intraprostatic brachytherapy dose volumes

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2803%2900558-2

7 January 2021

Gross hematuria after prostate brachytherapy

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2803%2900558-2

7 January 2021

Rectal dosimetric analysis following prostate brachytherapy

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2803%2900558-2

7 January 2021

Late rectal function after prostate brachytherapy.

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2803%2900558-2

7 January 2021

Rectal complications associated with transperineal interstitial brachytherapy for prostate cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2803%2900558-2

7 January 2021

Effect of post-implant edema on the rectal dose in prostate brachytherapy

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2803%2900558-2

7 January 2021

The effect of constipation on rectal dosimetry following prostate brachytherapy

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2803%2900558-2

7 January 2021

Late rectal bleeding after conformal radiotherapy of prostate cancer. II. Volume effects and dose-volume histograms.

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2803%2900558-2

7 January 2021

Adjuvant androgen deprivation impacts late rectal toxicity after conformal radiotherapy of prostate carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2803%2900558-2

7 January 2021

A comparison of radiation dose to the neurovascular bundles in men with and without prostate brachytherapy-induced erectile dysfunction

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2803%2900558-2

7 January 2021

Short-term sexual function after prostate brachytherapy

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2803%2900558-2

7 January 2021

Erectile function after permanent prostate brachytherapy

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2803%2900558-2

7 January 2021

Penile erectile function after permanent radioactive seed implantation for treatment of prostate cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2803%2900558-2

7 January 2021

Potency after permanent prostate brachytherapy for localized prostate cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2803%2900558-2

7 January 2021

Efficacy of sildenafil citrate in prostate brachytherapy patients with erectile dysfunction

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2803%2900558-2

7 January 2021

Prevention and management of erectile dysfunction following radical prostatectomy

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2803%2900558-2

7 January 2021

Sildenafil taken at bedtime significantly increases nocturnal erections: results of a placebo-controlled study.

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2803%2900558-2

7 January 2021

10.1016/S0090-4295(03)00558-2

Identifiers

DOI

1 reference

9 August 2017

1 reference